Labshake search
Citations for Stemcell Technologies :
701 - 750 of 1887 citations for Human Gastrin Cholecystokinin Type B Receptor CCKBR ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2023Quote: ... supplemented with 10 ng/ml human FGF2 (Stem Cell Technologies 78003). Individual iPSC colonies were mechanically picked ...
-
bioRxiv - Bioengineering 2023Quote: Human peripheral blood CD4+ T cells (Stem Cell Technologies, 200-0165) were cultured in ImmunoCult-XF T Cell Expansion media (Stem Cell Technologies ...
-
bioRxiv - Cell Biology 2023Quote: ... human iPSCs were passaged with Accutase (Stem Cell Technologies, Vancouver, Canada) and re-plated at a density of 1 to 2×105 per cm2 in growth factor reduced Matrigel (Corning Incorporated ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 10% NeuroCult™ Proliferation Supplement (Human) (STEMCELL Technologies, 05753), heparin solution (final concentration ...
-
bioRxiv - Bioengineering 2023Quote: ... 0.5ug/mL human recombinant Thrombopoietin (TPO) (StemCell Technologies, Cat. No. 78210), and 1% PSG (Thermofisher ...
-
bioRxiv - Bioengineering 2023Quote: Human peripheral blood CD8+ T cells (Stem Cell Technologies, 200-0164) were cultured in ImmunoCult XF T Cell Expansion media (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ... 20 ng/ml human basic fibroblast growth factor (Stemcell Technologies, 78003), 2 μg/ml heparin (Stemcell Technologies ...
-
bioRxiv - Developmental Biology 2024Quote: Primed H9 human ESC were cultured according in mTeSR1 (StemCell Technologies) according to the manufacturer’s guidance ...
-
Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer CellsbioRxiv - Immunology 2023Quote: ... ImmunoCult™ human CD3/CD28/CD2 T-cell activator (StemCell Technologies) was used to activate isolated T cells in vitro for 2 days following the manufacturer’s recommendations.
-
bioRxiv - Bioengineering 2024Quote: ... and 6 × 103 human bone marrow CD34+ cells (STEMCELL Technologies, 70002.3) into a collagen-based hydrogel according to the protocol described previously (49 ...
-
bioRxiv - Bioengineering 2024Quote: ... or ReLeSRTM human PSC selection and passaging reagent (Stemcell Technologies; 05872). The differentiation of iPSCs into foregut cells was performed using previously published protocols13,21 ...
-
bioRxiv - Cancer Biology 2024Quote: The RosetteSep™ Human CD45 Depletion Cocktail (Catalog #15112, StemCell Technologies) was used in this study to enrich cancer cells spiked into whole blood ...
-
bioRxiv - Neuroscience 2024Quote: ... with 10% human platelet-derived lysate (Stem Cell Technologies, Cat#06960) and 1% Penicillin-Streptomycin solution (Pen-Strep ...
-
bioRxiv - Cancer Biology 2022Quote: ... all the unwanted cells were labelled with magnet conjugated antibody cocktail which is separated using their EasySep magnetic stand leaving CD4 or CD8 cell in suspension using the vendor supplied EasySep Human CD4/CD8 T Cell Iso Kit (Stem Cell Technologies, 17952 for CD4 and 17953 for CD8). This negative selection approach results in isolation of untouched CD8 or CD4 T cells and stored frozen with 10% DMSO (MP Biomedicals ...
-
bioRxiv - Immunology 2022Quote: ... CD19+ cells were purified from C57BL/6 wild-type mice using the EasySep magnetic separation system (Stemcell Technologies, Vancouver, Canada) and were activated with lipopolysaccharide (10 μg/mL ...
-
bioRxiv - Genomics 2021Quote: Wild type SB AD3.1 [21] and AD/N3HAV lines were maintained as undifferentiated hiPSC in mTeSR1 medium (Stem Cell Technology) on 1:30 diluted Matrigel (hESC grade ...
-
bioRxiv - Bioengineering 2024Quote: ... each well of the 96 well plate was first coated with 45 μL 2.25% Type I Bovine Collagen Solution (StemCell Technologies) for 1 hour at 37 C ...
-
bioRxiv - Cancer Biology 2022Quote: ... BT179 and BT333 were maintained in NeuroCult proliferation medium (human) (StemCell Technologies) with 20 ng/ml EGF ...
-
bioRxiv - Molecular Biology 2021Quote: ... were suspended in Intesticult (INT) human organoid growth medium (Stem Cell Technologies) proliferation medium ...
-
bioRxiv - Neuroscience 2019Quote: ... ImmunoCult Human CD3/CD28 T cell Activator and 20ng rhIL2 (Stemcell Technologies) was added to culture medium ...
-
bioRxiv - Neuroscience 2019Quote: ... anti-human CD40 antibody (clone 5C3) and 20 ng rhIL4 (Stemcell Technologies) was added to culture medium ...
-
bioRxiv - Immunology 2021Quote: PBMCs were isolated from six human peripheral blood leukapheresis packs (STEMCELL Technologies) using Ficoll gradient density centrifugation ...
-
bioRxiv - Bioengineering 2021Quote: ... human iPSCs were cultured in mTeSR+ stem cell medium (Stem Cell Technologies) on Matrigel coated plates (Corning ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1), and 10 ng/mL GDNF ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Neuroscience 2021Quote: ... TNF alpha (0.5ng/mL final concentration in PBS, human recombinant, Stemcell Tech) was added to half of the wells ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 20 ng/ml human recombinant bFGF (Stem Cell Technologies cat# 78003). For 10 gBlocks pool ...
-
bioRxiv - Cancer Biology 2022Quote: ... and CD66b+ cells (RosetteSep Human CD45 Depletion Cocktail, STEMCELL Technologies Inc., Canada). Blood samples were incubated with RosetteSep Cocktail (50 μl per 1 ml blood ...
-
bioRxiv - Cell Biology 2022Quote: Endoderm induction was quantified using anti-human CD184(CXCR4)-PE (StemCell Technologies) and anti-human CD117(CKIT)-APC (ThermoFisher Scientific ...
-
bioRxiv - Bioengineering 2021Quote: Leukapheresis products from anonymous healthy human donors were purchased from STEMCELL Technologies, Inc ...
-
bioRxiv - Immunology 2022Quote: ... Human PBMCs were isolated by using Lymphoprep (Stemcell Technologies, Vancouver, BC, Canada) gradient centrifugation ...
-
bioRxiv - Bioengineering 2020Quote: Human hematopoietic progenitors were cultured in StemSpan SFEM I (Stem Cell Technologies) supplemented with human stem cell factor (hSCF ...
-
bioRxiv - Immunology 2020Quote: ... and 5 ng/mL recombinant human IL-15 (StemCell Technologies, Cat # 78031). Recombinant SARS-CoV-2 receptor binding domain was coated onto MaxiSorp 96-well plates (Thermo Scientific ...
-
bioRxiv - Systems Biology 2020Quote: Monocytes were enriched using RosetteSep human monocyte enrichment cocktail (Stem Cell Technologies) and purified by density gradient centrifugation ...
-
bioRxiv - Cell Biology 2020Quote: ... Human iPSCs were dissociated into single cells using Accutase (Stem Cell Technologies) at 37℃ for 10 min and then were seeded on to a vitronectin-coated six-well plate at 3×105 cell/well in mTeSR1 supplemented with 5μM ROCK inhibitor (Y-27632 ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... Human iPSCs were originally cultured in mTesR medium (STEMCELL Technologies, Cambridge, MA) and more recently in StemFlex medium (ThermoFisher ...
-
bioRxiv - Biochemistry 2019Quote: ... Commercial human blood plasma was purchased from STEMCELL Technologies (cat. no. 70039). Primary pediatric B-ALL and AML patient mononuclear cells enriched from bone marrow aspirates ...
-
bioRxiv - Immunology 2019Quote: RosetteSep Human CD4+ T Cell Enrichment Cocktail with SepMate-15 (STEMCELL Technologies) was used to remove non-CD4+ T-cells from fresh whole blood ...
-
bioRxiv - Bioengineering 2021Quote: Human ESC line H1 was maintained using mTeSR medium (Stemcell Technologies, 85850) on 1:200 Geltrex (Thermo fisher ...
-
bioRxiv - Cell Biology 2020Quote: Human iPSCs (WTc line1) were maintained in mTESR or mTESR+ (STEMCELL Technologies) on Matrigel (8 μg/ml ...
-
bioRxiv - Immunology 2021Quote: ... and human BAFF(71) in 80 mL StemCell medium A (StemCell Technologies) containing 6.3 µg/mL of CpG (phosphorothioate-modified oligodeoxynucleotide ZOEZOEZZZZZOEEZOEZZZT ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/ml human recombinant basic fibroblast growth factor (STEMCELL Technologies, 78003.1), and 0.679 U/ml heparin (Sigma ...
-
bioRxiv - Cancer Biology 2023Quote: ... human iPSCs grown on a Matrigel-coated surface in mTeSR1 (STEMCELL Technologies) were dissociated into single cells with Accutase (Life Technologies ...
-
bioRxiv - Bioengineering 2023Quote: Bone marrow-derived human CD34+ stem cells were purchased from Stemcell technologies and cultured in SFEM II medium (Stemcell technologies ...
-
bioRxiv - Immunology 2023Quote: ... or RosetteSepTM Human CD4+ T Cell Enrichment Cocktail (StemCell technologies, Vancouver, Canada) and centrifugation over a buoyant density medium (Lympholyte Cell Separation Medium ...
-
bioRxiv - Cancer Biology 2023Quote: ... Cells were re-suspended with MammoCult Human Medium (Stem cell technology #05620), and then 5000 cells per well were seeded on 6 well Ultra-low adherent plate (Corning #3471 ...
-
bioRxiv - Bioengineering 2023Quote: Human peripheral blood mononuclear cells were obtained from STEMCELL Technologies (cat#700.25.1). PBMCs were cultured and maintained in RPMI1640 with 10% fetal bovine serum (FBS ...